Marvell Technology Valuation
Is MRVL1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MRVL1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MRVL1 * (MX$1163) is trading above our estimate of fair value (MX$764.18)
Significantly Below Fair Value: MRVL1 * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MRVL1 *?
Other financial metrics that can be useful for relative valuation.
| What is MRVL1 *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$57.08b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 11x |
| Enterprise Value/EBITDA | 63x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does MRVL1 *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.2x | ||
NXPI NXP Semiconductors | 4.8x | 5.6% | US$65.5b |
MCHP Microchip Technology | 5.6x | -3.3% | US$49.7b |
IFX Infineon Technologies | 2.6x | 8.0% | €42.5b |
2454 MediaTek | 3.6x | 12.5% | NT$1.6t |
MRVL1 * Marvell Technology | 10x | 13.2% | Mex$57.1b |
Price-To-Sales vs Peers: MRVL1 * is expensive based on its Price-To-Sales Ratio (10x) compared to the peer average (4.2x).
Price to Earnings Ratio vs Industry
How does MRVL1 *'s PE Ratio compare vs other companies in the Global Semiconductor Industry?
Price-To-Sales vs Industry: MRVL1 * is expensive based on its Price-To-Sales Ratio (10x) compared to the Global Semiconductor industry average (3.3x).
Price to Sales Ratio vs Fair Ratio
What is MRVL1 *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 10x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate MRVL1 *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$1,163.00 | Mex$1,498.32 +28.8% | 9.7% | Mex$1,797.43 | Mex$1,112.70 | n/a | 31 |
| Apr ’25 | Mex$1,215.00 | Mex$1,462.88 +20.4% | 10.6% | Mex$1,751.04 | Mex$1,017.27 | n/a | 31 |
| Mar ’25 | Mex$1,291.33 | Mex$1,262.12 -2.3% | 12.1% | Mex$1,704.80 | Mex$954.69 | n/a | 30 |
| Feb ’25 | Mex$1,170.00 | Mex$1,237.64 +5.8% | 11.3% | Mex$1,720.87 | Mex$963.69 | n/a | 31 |
| Jan ’25 | Mex$1,041.00 | Mex$1,145.76 +10.1% | 11.0% | Mex$1,698.23 | Mex$951.01 | n/a | 31 |
| Dec ’24 | Mex$908.88 | Mex$1,163.18 +28.0% | 11.2% | Mex$1,719.70 | Mex$963.03 | n/a | 31 |
| Nov ’24 | Mex$849.50 | Mex$1,278.67 +50.5% | 11.9% | Mex$1,832.08 | Mex$1,025.96 | n/a | 30 |
| Oct ’24 | Mex$952.30 | Mex$1,197.06 +25.7% | 11.5% | Mex$1,712.61 | Mex$959.06 | n/a | 31 |
| Sep ’24 | Mex$942.00 | Mex$1,178.45 +25.1% | 11.0% | Mex$1,675.52 | Mex$1,005.31 | n/a | 30 |
| Aug ’24 | Mex$1,115.00 | Mex$1,183.78 +6.2% | 11.8% | Mex$1,698.40 | Mex$1,019.04 | n/a | 30 |
| Jul ’24 | n/a | Mex$1,152.30 0% | 11.7% | Mex$1,717.20 | Mex$944.46 | n/a | 29 |
| Jun ’24 | Mex$1,050.01 | Mex$1,158.13 +10.3% | 12.9% | Mex$1,762.49 | Mex$881.25 | n/a | 30 |
| May ’24 | Mex$700.00 | Mex$1,028.72 +47.0% | 19.4% | Mex$1,797.62 | Mex$808.93 | Mex$1,163.00 | 30 |
| Apr ’24 | Mex$779.00 | Mex$1,082.02 +38.9% | 19.3% | Mex$1,894.08 | Mex$852.34 | Mex$1,215.00 | 30 |
| Mar ’24 | Mex$807.00 | Mex$1,125.13 +39.4% | 23.9% | Mex$2,296.76 | Mex$753.34 | Mex$1,291.33 | 29 |
| Feb ’24 | Mex$862.00 | Mex$1,151.95 +33.6% | 23.8% | Mex$2,344.91 | Mex$769.13 | Mex$1,170.00 | 29 |
| Jan ’24 | Mex$702.46 | Mex$1,234.00 +75.7% | 22.9% | Mex$2,469.58 | Mex$810.02 | Mex$1,041.00 | 30 |
| Dec ’23 | Mex$868.30 | Mex$1,357.04 +56.3% | 20.4% | Mex$2,414.09 | Mex$1,004.26 | Mex$908.88 | 30 |
| Nov ’23 | Mex$791.00 | Mex$1,438.86 +81.9% | 20.8% | Mex$2,502.19 | Mex$1,040.91 | Mex$849.50 | 30 |
| Oct ’23 | n/a | Mex$1,490.40 0% | 18.5% | Mex$2,521.65 | Mex$1,170.05 | Mex$952.30 | 30 |
| Sep ’23 | Mex$905.00 | Mex$1,501.82 +65.9% | 18.4% | Mex$2,517.61 | Mex$1,168.17 | Mex$942.00 | 29 |
| Aug ’23 | Mex$1,114.00 | Mex$1,586.35 +42.4% | 21.4% | Mex$2,557.90 | Mex$1,111.97 | Mex$1,115.00 | 29 |
| Jul ’23 | Mex$863.00 | Mex$1,694.33 +96.3% | 17.5% | Mex$2,516.36 | Mex$1,207.85 | n/a | 29 |
| Jun ’23 | Mex$1,150.00 | Mex$1,685.52 +46.6% | 15.6% | Mex$2,450.09 | Mex$1,215.24 | Mex$1,050.01 | 29 |
| May ’23 | Mex$1,185.00 | Mex$1,909.96 +61.2% | 14.3% | Mex$2,551.09 | Mex$1,265.34 | Mex$700.00 | 28 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.